Abstract

Since its emergence in December 2019, the new coronavirus has killed tens of thousands of people. While social distancing limits the spread of the disease, it’s not enough to end the epidemic. Both vaccines and drugs are a great weapon against viruses, but they take a long time to create. This is why we turned to existing antiviral drugs. 

We chose an anti-HIV treatment because it showed positive results against other coronaviruses. A total of 200 adults with confirmed severe coronavirus infection participated in our trial. Half of them received the anti-HIV treatment while the others served as a control group. We found that these drugs weren’t particularly useful in patients with severe coronavirus infection. The treatment failed to speed up the patients’ improvement. It didn’t reduce the viral load, either. 

[This article is pending review]

Share this article

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Downloads

Additional languages
Only available in English.
Other recommended resources
Opening video(s)

About this article

Summary of research
Scientists wanted to know if anti-HIV drugs would improve the health of patients with severe COVID-19 infection.
Reading level
Scientific field
Key words
Scientific methods
Type of figure
AP Environmental science topics
IB Biology topics
Location of research
Scientist Affiliation
Publication date
April 2020

Looking for something else?